US 8075900
Melanoma associated peptide analogues and vaccines against melanoma
granted A61KA61K38/00A61P
Quick answer
US patent 8075900 (Melanoma associated peptide analogues and vaccines against melanoma) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61P, A61P37/04